Back to search
FDAFDA · Food and drugs·Recall number D-0643-2022

PARAGARD T380A (intrauterine copper contraceptive), 1 unit per carton together with an insertion tube and solid white rod in a Tyvek polyethylene pouch, Rx Only, Manufactured by Teva Women's Health Inc. a subsidiary of Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 51285-204-01

Published February 23, 2022 · Recall initiated: February 4, 2022

Summary

FDA records drug Class I recall D-0643-2022, published February 23, 2022 and initiated February 4, 2022. Recalling firm: CooperSurgical, Inc; Status: Terminated; Reported quantity: 48,645 cartons; Lot: Lot # 517001,Exp 1/2024. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Non-sterility

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
CooperSurgical, Inc
Distributor
US Nationwide
Lot
Lot # 517001,Exp 1/2024
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was PARAGARD T380A (intrauterine copper contraceptive), 1 unit per carton together with an insertion tube and solid white rod in a Tyvek polyethylene pouch, Rx Only, Manufactured by Teva Women's Health Inc. a subsidiary of Teva Pharmaceuticals USA, Inc., North Wales, PA 19454, NDC 51285-204-01 recalled?

Yes. FDA published recall D-0643-2022 on February 23, 2022. Reported hazard: Non-sterility

What should I do if I have this product?

Voluntary: Firm initiated · Letter